Robert W. Baird Issues Pessimistic Forecast for Concentrix (NASDAQ:CNXC) Stock Price

Concentrix (NASDAQ:CNXC) had its price target decreased by Robert W. Baird from $52.00 to $40.00 in a research note issued on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s target price points to a potential upside of 44.30% from the company’s current price.

Several other equities research analysts also recently issued reports on the company. Weiss Ratings downgraded Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a report on Thursday, January 29th. Wall Street Zen upgraded shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Finally, Barrington Research reissued an “outperform” rating and set a $62.00 price target on shares of Concentrix in a research report on Tuesday, March 17th. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $48.50.

Concentrix Stock Performance

NASDAQ:CNXC opened at $27.72 on Wednesday. Concentrix has a fifty-two week low of $24.27 and a fifty-two week high of $66.00. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.40 and a current ratio of 1.18. The company has a 50 day moving average price of $34.72 and a 200 day moving average price of $40.14. The stock has a market capitalization of $1.70 billion, a P/E ratio of -1.29, a PEG ratio of 0.26 and a beta of 0.50.

Concentrix (NASDAQ:CNXC) last announced its earnings results on Tuesday, March 24th. The company reported $2.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.65 by ($0.04). Concentrix had a negative net margin of 13.35% and a positive return on equity of 17.80%. The firm had revenue of $2.50 billion during the quarter, compared to analysts’ expectations of $2.49 billion. During the same period in the previous year, the firm earned $2.79 EPS. The firm’s revenue for the quarter was up 5.4% compared to the same quarter last year. Equities research analysts forecast that Concentrix will post 10.11 EPS for the current year.

Insider Buying and Selling at Concentrix

In other Concentrix news, CEO Christopher A. Caldwell bought 1,000 shares of the company’s stock in a transaction that occurred on Thursday, January 29th. The shares were purchased at an average price of $37.07 per share, with a total value of $37,070.00. Following the completion of the acquisition, the chief executive officer directly owned 362,075 shares of the company’s stock, valued at $13,422,120.25. This represents a 0.28% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.90% of the company’s stock.

Institutional Trading of Concentrix

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Royal Bank of Canada boosted its stake in Concentrix by 9.5% during the 1st quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock worth $2,643,000 after purchasing an additional 4,133 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Concentrix by 75.1% in the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after buying an additional 181,546 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Concentrix by 17.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after buying an additional 21,746 shares during the last quarter. Focus Partners Wealth acquired a new stake in shares of Concentrix during the first quarter worth about $781,000. Finally, Geneos Wealth Management Inc. grew its holdings in shares of Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after buying an additional 522 shares during the last quarter. Institutional investors and hedge funds own 90.34% of the company’s stock.

Key Headlines Impacting Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Several firms cut targets but kept constructive ratings — Canaccord cut its target to $55 and kept a Buy rating, Barrington cut to $38 but stayed Outperform, and Robert W. Baird trimmed to $40 while maintaining Outperform — signaling analysts still see upside versus the current price. Article Title
• Positive Sentiment: Some analysts continue to view CNXC as undervalued on a forward P/E basis and as a potential rebound candidate if margins and cash flow recover in H2 2026. Article Title
• Neutral Sentiment: Company revenue modestly beat estimates ($2.50B vs ~$2.49B), showing continued top-line growth even as profitability slipped. Earnings/Stats
• Neutral Sentiment: Macro/market coverage: Bloomberg flagged CNXC among “stock movers,” reflecting the heavy trading and news-driven volatility rather than a single structural change. Stock Movers
• Negative Sentiment: Margin squeeze and cautious 2026 guidance triggered a large selloff — investors reacted to lower margin outlook and conservative revenue/cash-flow assumptions. Yahoo Finance
• Negative Sentiment: Analyst and investor skepticism: Seeking Alpha pieces highlight execution risk from an expensive transition to AI-driven services, negative Q1 free cash flow, high leverage and a downgraded stance that argues CNXC is “cheap for a reason.” SA Downgrade
• Negative Sentiment: Investor caution pieces reinforce the risks — another Seeking Alpha article explains why some investors are avoiding CNXC despite low valuation multiples. SA Opinion
• Negative Sentiment: Price action: coverage noted CNXC hit a new 1‑year low after the earnings miss, underscoring near-term downside pressure until margins and cash flow show clear improvement. 1-Year Low

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.